Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Senate FDA reform bill

This article was originally published in The Tan Sheet

Executive Summary

Senate FDA reform bill: Excessive floor amendments could kill Sen. Nancy Kassebaum's (R-Kan.) FDA reform legislation (S 1477), Senate Labor & Human Resources Committee Health Policy Advisor Jane Williams warned May 13 at the Food & Drug Law Institute's "Pharmaceutical Update" meeting in Washington, D.C. Williams asserted that because of the limited time left in this session, the bill will never reach the floor if too many time-consuming amendments are filed. S 1477 is expected to be reported out of committee the week of May 20...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts